Abortion Pill Deadline Stuns Seoul

Medicine pills and syringe on table with brown bottle — Photo: Adul10 / Shutterstock

South Korea plans to let women take abortion pills starting in early 2027, ending a seven-year gap between a court ruling and an actual law.

Story Snapshot

South Korea’s government set a target of the first quarter of 2027 to introduce abortion pills for pregnancies up to nine weeks.
Women will need a prescription and must get the pills only through hospitals or clinics, at least for the first two years.
The plan comes seven years after the Constitutional Court struck down the country’s abortion ban as unconstitutional in 2019.
Lawmakers still have not passed a replacement law, so regulators are moving ahead through administrative approval instead.

What The Government Actually Announced

Won Min-kyong, South Korea’s Minister of Gender Equality and Family, said Wednesday that women up to nine weeks pregnant could get abortion pills by prescription. She said the first rollout, starting in the first quarter of 2027, will run for at least two years. The Ministry of Health and Welfare, the Ministry of Food and Drug Safety, and her ministry made the joint announcement at a briefing in Seoul.

The drug at the center of the plan is Mifegyne, a mifepristone-misoprostol combination sold legally in dozens of countries for decades. Hyundai Pharmaceutical filed its third application for approval in December 2024, after two earlier attempts in 2021 and 2023 stalled over paperwork issues. Regulators plan to review the application without requiring a separate clinical trial on Korean patients, arguing the drug’s track record abroad is enough.

Why It Took Seven Years To Get Here

South Korea’s Constitutional Court ruled in April 2019 that the country’s abortion ban violated the constitution. The criminal penalty for abortion officially lost its legal force at the start of 2021. Lawmakers never passed a replacement law spelling out how legal abortion should actually work. That left abortion pills stuck in a regulatory grey zone, technically not illegal to use but never approved for sale.

Health officials had long argued that new legislation needed to come first before any drug could be approved. That position changed after the Ministry of Government Legislation issued an interpretation last month stating abortion pills could be approved even without a new law on the books. That legal opinion appears to be what finally unlocked the government’s timeline.

Rules For Who Can Get The Pills And How

Under the proposal, the pills will only go to women who are no more than nine weeks pregnant. That is a narrower window than the World Health Organization’s standard of up to 12 weeks. For the first two years, prescriptions and dispensing will happen only inside hospitals or clinics, not through pharmacies directly.

One detail regulators still have not settled is whether minors will need parental consent before receiving the pills. The government has said it needs more time to review that question separately from the main rollout plan. Officials say the phased, hospital-only approach for adults is meant to prioritize safety while the system is new.

The Bigger Picture Behind The Policy Shift

The Ministry of Food and Drug Safety says it will not fast-track the drug purely for political reasons. It has stated it will thoroughly review the actual approval application materials before signing off, regardless of the announced target date. Hyundai Pharm’s application specifically covers Mifegymiso, and that filing remains formally under review as of this announcement.

S Korea nears approval of abortion pill
South Korea could allow the use of the abortion pill Mifegyne as early as this year, as the government nears the end of its approval review.https://t.co/nMwWcMt9AD

— The Asian Feminist / @theasianfeminist.bsky.social (@theasianfmnst) September 16, 2026

Reporting also notes religious groups and some doctors have raised concerns about the plan, while women’s health advocates have pushed for faster action given the seven-year delay. That split reflects a debate familiar to Americans on both sides of the abortion issue: how to balance access, safety oversight, and moral objections when a court ruling outpaces the legislature. South Korea’s leaders chose administrative action over waiting indefinitely for lawmakers to act, a decision that will shape reproductive policy for the country’s next generation.